Fig. 1From: A predictive model for advanced oropharyngeal cancer patients treated with chemoradiationThe 1-year and 2-year OS rates for advanced oropharyngeal cancer patients with Hb ≥ 13.5 g/dl versus Hb < 13.5 g/dl were 88 and 67% versus 55 and 33%, respectivelyBack to article page